Irvine, CA-based Masimo CorporationMASI recently announced the availability of the RD SedLine EEG sensor, which can be used with the company's flagship SedLine Brain Function Monitoring technology. In ...

In a recent breakthrough, Masimo Corporation MASI announced that its Next Generation SedLine brain function monitoring has received clearance from the FDA. The device will provide clinicians real-time ...

Noting that pEEG-guided anesthesia may improve hemodynamic stability and that high postoperative doses of vasoactive and inotropic drugs have been associated with mortality and renal dysfunction, the ...

Irvine-based Masimo Corp., which makes patient monitoring devices, said a study found one of its products effectively monitored babies and toddlers undergoing surgeries. Researchers wanted to measure ...

Masimo Corporation MASI recently announced findings of a study that evaluated the ability of the Patient State Index (PSi) and Suppression Ratio (“SR”) parameters provided by Masimo SedLine brain ...

Masimo Corporation MASI recently announced the findings of a favorable study result wherein researchers evaluated the relationship between parameters derived from electroencephalogram (EEG) spectra ...

IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) announced today FDA clearance of Next Generation SedLine ® brain function monitoring. SedLine helps clinicians monitor the state of the brain ...

NEUCHATEL, Switzerland--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) announced today the CE marking of Next Generation SedLine ® brain function monitoring for pediatric patients (1-18 years of age). With ...

EEG-Guided Anesthesia Using Masimo Technology Significantly Reduced Pediatric Anesthesia Emergence Delirium, Time to Emergence and Discharge, and Cost of Care by Minimizing Sevoflurane Exposure ...

Masimo (NASDAQ: MASI) announced today the CE mark and scheduled full market release of Next Generation SedLine ® Brain Function Monitoring technology at the European Society of Anaesthesiology’s (ESA) ...